Introduction to gene therapy and guidelines to pharmaceutical development

Pharmaceutical Gene Delivery Systems

Volumn , Issue , 2003, Pages 1-16

  Sullivan, Sean M ^a  

^a UNIVERSITY OF FLORIDA   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

EID: 84255167598     PISSN: None     EISSN: None     Source Type: Book    
DOI: None     Document Type: Chapter

References (20)

1. Verma IM, Somia N. Gene therapy-promises, problems and prospects. Nature 1997; 389(6648):239-242.
2. Cavazzana-Calvo M, Hacein-Bey S, de-Saint-Basile G, Gross F, Yvon E, Nusbaum P, Selz F, Hue C, Certain S, Casanova J-L, Bousso P, Deist F-L, Fischer A. Gene therapy of human severe combined immunodeficiency (SCID)-X1 disease. Science, 2000; 288(5466):669-672.
3. Hacein-Bey H, Cavazzana-Calvo M, Le Deist F, Dautry-Varsat A, Hivroz C, Riviere I, Danos O, Heard JM, Sugamura K, Fischer A, De Saint Basile G. Gamma-c gene transfer into SCID X1 patients’ B-cell lines restores normal high-affinity interleukin-2 receptor expression and function. Blood 1996; 87(8):3108-3116.
4. Hacein-Bey S, Gross F, Nusbaum P, Hue C, Hamel Y, Fischer A, Cavazzana-Calvo M. Optimization of retroviral gene transfer protocol to maintain the lymphoid potential of progenitor cells. Hum Gene Ther 2001; 12(3):291-301.
5. High KA, AAV-mediated gene transfer for hemophilia. Ann NY Acad Sci 2001; 953:64-74.
6. Wolff JA, Malone RW, Williams P, Chong W, Acsadi G, Jani A, Felgner PL. Direct gene transfer into mouse muscle in vivo. Science 1990; 247(4949 Pt 1):1465-1468.
7. Felgner PL. DNA vaccines. Curr Biol 1998; 8(16):R551-553.
8. Isner JM, Ropper A, Hirst K. VEGF gene transfer for diabetic neuropathy. Hum Gene Ther 2001; 12(12):1593-1594.
9. Fewell JG, MacLaughlin F, Mehta V, Gondo M, Nicol F, Wilson E, Smith LC. Gene therapy for the treatment of hemophilia B using PINC-formulated plasmid delivered to muscle with electroporation. Mol Ther 2001; 3(4):574-583.
10. Shibata MA, Morimoto J, Otsuki Y. Suppression of murine mammary carcinoma growth and metastasis by HSVtk/GCV gene therapy using in vivo electroporation. Cancer Gene Ther 2002; 9(1):16-27.
11. Cupp CL, Bloom DC. Gene therapy, electroporation, and the future of wound-healing therapies. Facial Plast Surg 2002; 18(1):53-58.
12. Yamashita Y, Shimada M, Tanaka S, Okamamoto M, Miyazaki J, Sugimachi K. Electroporation-mediated tumor necrosis factor-related apoptosis-inducing ligand (TRAIL)/ Apo2L gene therapy for hepatocellular carcinoma. Hum Gene Ther 2002; 13(2):275-286.
13. Nakano A, Matsumori A, Kawamoto S, Tahara H, Yamato E, Sasayama S, Miyazaki JI. Cytokine gene therapy for myocarditis by in vivo electroporation. Hum Gene Ther 2001; 12(10):1289-1297.
14. Anwer K, Kao G, Proctor B, Anscombe I, Florack V, Earls R, Wilson E, McCreery T, Unger E, Rolland A, Sullivan SM. Ultrasound enhancement of cationic lipidmediated gene transfer to primary tumors following systemic administration. Gene Ther 2000; 7(21):1833-1839.
15. Tan Y, Whitmore M, Li S, Frederik P, Huang L. LPD nanoparticles-novel nonviral vector for efficient gene delivery. Methods Mol Med 2002; 69:73-81.
16. Shi N, Zhang Y, Zhu C, Boado RJ, Pardridge WM. Brain-specific expression of an exogenous gene after i.v. administration. Proc Natl Acad Sci USA 2001; 98(22):12754-12759.
17. Fenske DB, MacLachlan I, Cullis PR. Stabilized plasmid-lipid particles: a systemic gene therapy vector. Methods Enzymol 2002; 346:36-71.
18. Anwer K, Bailey A, Sullivan SM. Targeted gene delivery: a two-pronged approach. Crit Rev Ther Drug Carrier Syst 2000; 17(4):377-424.
19. Laitinen M, Hartikainen J, Hiltunen MO, Eranen J, Kiviniemi M, Narvanen O, Maki-nen K, Manninen H, Syvanne M, Martin JF, Laakso M, Yla-Herttuala S. Catheter-mediated vascular endothelial growth factor gene transfer to human coronary arteries after angioplasty. Hum Gene Ther 2000; 11(2):263-270.
20. Lesko LJ, Rowland M, Peck CC, Blaschke TF. Optimizing the science of drug development: opportunities for better candidate selection and accelerated evaluation in humans. J Clin Pharm 2000; 40:803-814.